COVAXIN, developed by the Indian Council of Medical Research and Bharat Biotech, is being tested at 12 institutes across India.

Bharat Biotech proudly announces the animal study results of COVAXIN — these results demonstrate the protective efficacy in a live viral challenge model,” the Hyderabad-based firm said.